• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

The Investigation of tumor suppression effect of EP4 receptor inhibitors in glioblastoma

Research Project

  • PDF
Project/Area Number 21591839
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Cerebral neurosurgery
Research InstitutionTottori University

Principal Investigator

WATANABE Takashi  鳥取大学, 医学部, 教授 (00175100)

Co-Investigator(Kenkyū-buntansha) KAMBE Atsushi  鳥取大学, 医学部, 助教 (70348283)
Project Period (FY) 2009 – 2011
Keywords膠芽腫 / プロスタグランジンE2受容体EP4 / EGFR
Research Abstract

We have investigated the tumor suppression effects of selective inhibitors of Prostaglandin E2 receptor, EP4 in human glioblastoma cells. The EP4 expression in malignat gliomas were higher relative to the lower grade gliomas on Immunohistochemistry staining and Western blotting analysis. The selective EP4 receptor inhibitors ONO-AE3-208 and ONO-AE1-328 exhibited the effects of tumor proliferation suppression, tumor invasion suppression and apoptosis induction at high-dose concentrations(50-100uM). They indicated the necessity of further conditional investigations to perform in vivo experiments.

  • Research Products

    (2 results)

All 2011 2010

All Presentation (2 results)

  • [Presentation] The COX inhibitor, sulindac sulfide inhibits EP4 expression and suppresses the growth of Glioblastoma cells2011

    • Author(s)
      神部敦司
    • Organizer
      12^<th> International Conference on Bioactive Lipids in Cancer
    • Place of Presentation
      Seattle, USA
    • Year and Date
      2011-09-19
  • [Presentation] The cyclooxygenase inhibitors inhibit EP4 expression and suppresses the growth of glioblastoma cells2010

    • Author(s)
      神部敦司
    • Organizer
      Joint Neurosurgical Convention 2010
    • Place of Presentation
      Hawaii, USA
    • Year and Date
      2010-01-25

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi